Found 28 matching trials
RWE About QOL and Compliance of Patients With OFS in China N/A The purpose of this study is to assess the patient's feedback from using Gn...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer PHASE3 RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Show More Location
Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
Learn More & Join Trial
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy N/A Hormone receptor-positive breast cancer accounts for about 70% of all breas...
Show More Location
Cancer Hospital Affiliated to Harbin Medical University
Learn More & Join Trial
Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer PHASE2 To explore the efficacy and safety of chidamide combined with endocrine in ...
Show More Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk PHASE4 Among ER+HER2- premenopausal patients with N1 who undergoes primary breast ...
Show More Location
Gangnam Severance Hospital
Learn More & Join Trial
Premenopausal Endocrine Responsive Chemotherapy Trial PHASE3 The PERCHE trial evaluated the worth of adding adjuvant chemotherapy for pr...
Show More Location
National Institute of Oncology
Learn More & Join Trial
CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer PHASE3 The investigators designed a phase III clinical trial involving hormone rec...
Show More Location
Multiple Locations
Learn More & Join Trial
ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer Patients N/A The principal aim of this prospective observational study is to investigate...
Show More Location
IRCCS Ospedale Policlinico San Martino
Learn More & Join Trial
Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer PHASE2 This is a multicenter, open-label, single-arm, one-stage, phase II study to...
Show More Status
Active Not Recruiting
Location
UMHAT Sveti Ivan Rilski EAD Department of Medical Oncology
Learn More & Join Trial
Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES) PHASE3 CDK4/6 inhibitors are currently the standard treatment for female breast ca...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial